These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 10701745)

  • 21. Radiobiologic significance of apoptosis and micronucleation in quiescent cells within solid tumors following gamma-ray irradiation.
    Masunaga S; Ono K; Suzuki M; Kinashi Y; Takagaki M
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1361-8. PubMed ID: 11286844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.
    Masunaga S; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Suzuki M; Nagata K; Nagasawa H; Uto Y; Hori H
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):21-8. PubMed ID: 12618897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.
    Masunaga SI; Ono K; Suzuki M; Kinashi Y; Takagaki M; Hori H; Kasai S; Nagasawa H; Uto Y
    Jpn J Cancer Res; 2000 May; 91(5):566-72. PubMed ID: 10835503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of combination with both continuous administration of hypoxic cytotoxin and mild temperature hyperthermia in boron neutron capture therapy in terms of local tumor response and lung metastatic potential.
    Masunaga SI; Sakurai Y; Tanaka H; Takata T; Suzuki M; Sanada Y; Tano K; Maruhashi A; Ono K
    Int J Radiat Biol; 2019 Dec; 95(12):1708-1717. PubMed ID: 31545117
    [No Abstract]   [Full Text] [Related]  

  • 25. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy.
    Ono K; Masunaga SI; Kinashi Y; Takagaki M; Akaboshi M; Kobayashi T; Akuta K
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1081-6. PubMed ID: 8600091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
    Masunaga S; Ono K; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Nagasawa H; Uto Y; Hori H
    Cancer Sci; 2003 Jan; 94(1):125-33. PubMed ID: 12708486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiobiological characteristics of solid tumours depending on the p53 status of the tumour cells, with emphasis on the response of intratumour quiescent cells.
    Masunaga S; Ono K; Takahashi A; Ohnishi T; Kinashi Y; Takagaki M
    Eur J Cancer; 2002 Mar; 38(5):718-27. PubMed ID: 11916556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alteration of radiosensitivity of quiescent cell populations in solid tumors irradiated with X-rays twice at various intervals.
    Masunaga S; Ono K; Mitsumori M; Abe M
    Jpn J Cancer Res; 1993 Nov; 84(11):1130-5. PubMed ID: 8276718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of p53 Status of Tumor Cells on Radiosensitivity of Irradiated Tumors With Carbon-Ion Beams Compared With γ-Rays or Reactor Neutron Beams.
    Masunaga SI; Uzawa A; Hirayama R; Matsumoto Y; Sakurai Y; Tanaka H; Tano K; Sanada Y; Suzuki M; Maruhashi A; Ono K
    World J Oncol; 2015 Aug; 6(4):398-409. PubMed ID: 28983338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumors.
    Masunaga S; Ono K; Akaboshi M; Takagaki M; Kinashi Y; Suzuki M; Abe M
    Radiat Med; 1997; 15(1):37-43. PubMed ID: 9134583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia.
    Masunaga S; Ono K; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Takagaki M
    Jpn J Cancer Res; 1997 Aug; 88(8):770-7. PubMed ID: 9330609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
    Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1999; 17(4):259-64. PubMed ID: 10510897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in oxygenation status in intratumour total and quiescent cells following gamma-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment.
    Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
    Br J Radiol; 2000 Sep; 73(873):978-86. PubMed ID: 11064652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of the high-LET radiations from the boron neutron capture [10B(n,α) 7Li] reaction determined for induction of chromosome aberrations and apoptosis in lymphocytes of human blood samples.
    Schmid TE; Canella L; Kudejova P; Wagner FM; Röhrmoser A; Schmid E
    Radiat Environ Biophys; 2015 Mar; 54(1):91-102. PubMed ID: 25428113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dependency of the effect of a vascular disrupting agent on sensitivity to tirapazamine and gamma-ray irradiation upon the timing of its administration and tumor size, with reference to the effect on intratumor quiescent cells.
    Masunaga S; Nagasawa H; Nagata K; Suzuki M; Uto Y; Hori H; Kinashi Y; Ono K
    J Cancer Res Clin Oncol; 2007 Jan; 133(1):47-55. PubMed ID: 16924543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The response of quiescent cell populations in murine solid tumors to irradiation with fast neutrons.
    Masunaga S; Ono K; Akuta K; Akaboshi M; Abe M; Ando K; Koike S
    Acta Oncol; 1994; 33(7):813-7. PubMed ID: 7993651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.
    Masunaga S; Sakurai Y; Tanaka H; Suzuki M; Liu Y; Kondo N; Maruhashi A; Kinashi Y; Ono K
    Br J Radiol; 2012 Mar; 85(1011):249-58. PubMed ID: 22391496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The radiosensitivity of total and quiescent cell populations in solid tumors to 290 MeV/u carbon ion beam irradiation in vivo.
    Masunaga S; Ando K; Uzawa A; Hirayama R; Furusawa Y; Koike S; Ono K
    Acta Oncol; 2008; 47(6):1087-93. PubMed ID: 18607878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
    Masunaga S; Kasaoka S; Maruyama K; Nigg D; Sakurai Y; Nagata K; Suzuki M; Kinashi Y; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1515-22. PubMed ID: 17126210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.